In this study, we established TACC3 expression levels as a novel prognostic signature for NSCLC by predicting the correlation between TACC3 expression and clinical prognosis using non-invasive CT-based radiomics analysis. The gene discussed is TACC3; the disease is non-small cell lung carcinoma.